HomeProduct Complimentary download Ceres Inc. announces pricing of $1.5 million financing

Ceres Inc. announces pricing of $1.5 million financing

Keyword:
Publish time: 27th July, 2015      Source: Thousand Oaks, California, USA
Information collection and data processing:  CCM     For more information, please contact us
Ceres Inc. announces pricing of $1.5 million financingCeres Inc. announces pricing of $1.5 million financing" title="Share this link on Facebook">Thousand Oaks, California, USAJuly 27, 2015Ceres, Inc. (NASDAQ: CERE), an agricultural biotechnology company, today announced that it has entered into a securities purchase agreement with certain institutional investors providing for the purchase and sale of 1,200,000 shares of common stock at a price of $1.296 per share and warrants to purchase up to 1,200,000 shares of common stock with an exercise price of $1.62 per share. The warrants will be exercisable six months following the date of issuance and will expire five years from the date they become exercisable.Ladenburg Thalmann & Co. Inc., a subsidiary of Ladenburg Thalmann Financial Services Inc., is acting as exclusive placement agent in connection with the offering.The closing of the sale of the securities is expected to take place on or about July 30, 2015, subject to the satisfaction of customary closing conditions.The shares of common stock were offered pursuant to a shelf registration statement on Form S？3 (File No. 333-204024), which was declared effective by the United States Securities and Exchange Commission ("SEC") on July 17, 2015. The warrants and shares issuable upon exercise of the warrants were offered in a concurrent private placement and have not been registered under the Securities Act of 1933, as amended. Ceres has agreed to file one or more registration statements with the SEC covering the resale of the shares of common stock issuable upon exercise of the warrants.This press release does not constitute an offer to sell or the solicitation of an offer to buy, nor will there be any sales of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. A prospectus supplement relating to the shares of common stockwill be filed by Ceres with the SEC. When available, copies of the prospectus supplement, together with the accompanying prospectus, can be obtained at the SEC's website at www.sec.gov or from Ladenburg Thalmann & Co. Inc., Prospectus Department, 570 Lexington Avenue, 11th Floor, New York, New York 10022, by calling (212) 409-2000.About Ceres Ceres, Inc. is an agricultural biotechnology company that develops and markets seeds and traits to produce crops for animal feed, sugar and other markets. The company's advanced plant breeding and biotechnology technology platforms, which can increase crop productivity, improve quality, reduce crop inputs and improve cultivation on marginal land, have broad application across multiple crops, including food, feed, fiber and fuel crops. Ceres markets its seed products under its Blade brand. The company also licenses its biotech traits and technology, including its Persephone genome visualization software, to other life science companies and organizations.More news from: Ceres, Inc.Website: http://www.cnchemicals.com/: July 27, 2015The news item on this page is copyright by the organization where it originatedFair use notice